An estimated 7 million patients have already used some form of digital health program featuring connected devices as part of a care plan, a statistic that is predicted to reach 50 million by 2020. Recent work by BCC Research explores the expanding world of mobile health (mHealth) care plans, apps, and devices in the United States, Europe, and Japan. The mHealth revolution is being driven by cultural differences, Internet of Things technology, and network connectivity, as well as new patient-centered health policy initiatives.
Ensuring safety of the blood supply, the demand for plasma-derived therapeutics, and an aging population are factors driving growth in the global blood industry. The annual growth of plasma-derived therapies, used mostly to treat rare disorders, may exceed 10%. Hemophilia, hepatitis, cancer, and kidney failure are among the many conditions that are managed by blood transfusion or by therapy with plasma or plasma-derived products. An aging population suggests that there will be many more patients who need such products in the future. At a compound annual growth rate (CAGR) of 4.9%, BCC Research predicts the value of the global blood industry to increase from $33.5 billion in 2016 to $42.6 billion in 2021.
BCC Research recently analyzed the global market for bionic devices, assessing the latest sensor and material technologies that are being used in advanced bionic ears, eyes, hearts, limbs, and exoskeletons. These bionic components are driving market growth and changing the lives of millions of people.
Medical device coatings are essential to healthcare. Up to 80% of medical devices require at least one type of coating material or surface treatment. Coatings that enhance biocompatibility have improved the quality of implanted electronic devices and artificial joints. Catheters and examining room surfaces with antimicrobial coatings have become frontline defenses against antibiotic-resistant infections such as MRSA.